Mulpleta

Chemical Namelusutrombopag
Dosage FormTablet (oral; 3 mg)
Drug ClassReceptor agonists
SystemBlood
CompanyShionogi Inc.
Approval Year2018

Indication

  • To treat thrombocytopenia pin adults with chronic liver disease prior to surgical procedures.
Last updated on 11/2/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Mulpleta (Lusutrombopag) Prescribing Information 2018Shionogi Inc., Florham Park, NJ